JPMorgan Chase & Co’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Buy |
1,141,911
+825,732
| +261% | +$9.27M | ﹤0.01% | 2033 |
|
|
2025
Q1 | $1.44M | Sell |
316,179
-101,360
| -24% | -$463K | ﹤0.01% | 3449 |
|
|
2024
Q4 | $2.35M | Sell |
417,539
-1,230,305
| -75% | -$6.94M | ﹤0.01% | 3288 |
|
|
2024
Q3 | $7.98M | Sell |
1,647,844
-43,508
| -3% | -$211K | ﹤0.01% | 2317 |
|
|
2024
Q2 | $8.25M | Buy |
1,691,352
+198,302
| +13% | +$968K | ﹤0.01% | 2229 |
|
|
2024
Q1 | $19.8M | Sell |
1,493,050
-565,349
| -27% | -$7.51M | ﹤0.01% | 1688 |
|
|
2023
Q4 | $28.7M | Sell |
2,058,399
-447,497
| -18% | -$6.24M | ﹤0.01% | 1389 |
|
|
2023
Q3 | $33.2M | Buy |
2,505,896
+666,910
| +36% | +$8.84M | ﹤0.01% | 1204 |
|
|
2023
Q2 | $34.5M | Sell |
1,838,986
-69,378
| -4% | -$1.3M | ﹤0.01% | 1194 |
|
|
2023
Q1 | $27.5M | Buy |
1,908,364
+119,902
| +7% | +$1.73M | ﹤0.01% | 1277 |
|
|
2022
Q4 | $34.6M | Sell |
1,788,462
-130,028
| -7% | -$2.52M | ﹤0.01% | 1136 |
|
|
2022
Q3 | $65.9M | Buy |
1,918,490
+563,852
| +42% | +$19.4M | 0.01% | 840 |
|
|
2022
Q2 | $20.7M | Buy |
1,354,638
+235,804
| +21% | +$3.6M | ﹤0.01% | 1414 |
|
|
2022
Q1 | $25.5M | Buy |
1,118,834
+241,536
| +28% | +$5.51M | ﹤0.01% | 1387 |
|
|
2021
Q4 | $32.3M | Sell |
877,298
-22,567
| -3% | -$832K | ﹤0.01% | 1279 |
|
|
2021
Q3 | $42.3M | Sell |
899,865
-20,387
| -2% | -$958K | 0.01% | 1151 |
|
|
2021
Q2 | $55.4M | Buy |
+920,252
| New | +$55.4M | 0.01% | 1080 |
|